APA (7th ed.) Citation

Putra, G. E. P., Ulfah, M., Hafizh, N., Prabandari, E. E., Firdayani, & Helianti, I. (2023). Characterisation of recombinant 3CL protease from SARS-CoV-2 produced in E. coli BL21 (DE3) for screening anti-covid drug candidates using rhodamine 110-synthetic peptide conjugate as a substrate. Penerbit Universiti Kebangsaan Malaysia.

Chicago Style (17th ed.) Citation

Putra, Gede Eka Perdana, Maria Ulfah, Naufal Hafizh, Erwahyuni Endang Prabandari, Firdayani, and Is Helianti. Characterisation of Recombinant 3CL Protease from SARS-CoV-2 Produced in E. Coli BL21 (DE3) for Screening Anti-covid Drug Candidates Using Rhodamine 110-synthetic Peptide Conjugate as a Substrate. Penerbit Universiti Kebangsaan Malaysia, 2023.

MLA (9th ed.) Citation

Putra, Gede Eka Perdana, et al. Characterisation of Recombinant 3CL Protease from SARS-CoV-2 Produced in E. Coli BL21 (DE3) for Screening Anti-covid Drug Candidates Using Rhodamine 110-synthetic Peptide Conjugate as a Substrate. Penerbit Universiti Kebangsaan Malaysia, 2023.